Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study.

ABSTRACT:

SUBMITTER: Henderson JJ 

PROVIDER: S-EPMC8906457 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature